OpenAlex
PricingAboutJobs
Log inGet started
Work

Osimertinib: First Global Approval

HTML

Year: 2016
Type: review
Source: Drugs
DOI: 10.1007/s40265-015-0533-4
Author: Sarah L. Greig
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: osimertinib, EGFR tyrosine kinase inhibitors, non-small cell lung cancer, T790M mutation, accelerated approval, drug development milestones, oral anticancer drugs, first-line and second-line treatment, adjuvant therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2286158735
FWCI: 5.393
Cites: 24
Cited by: 362
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms